Mack J. Pharma promotional spending in 2013. Pharma Marketing News. 2014;13(5):1-6.
Brax H, Fadlallah R, Al-Khaled L, et al. Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis. PLoS One. 2017;12(4):e0175493. doi:10.1371/journal.pone.0175493
Spurling GK, Mansfield PR, Montgomery BD, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS Med. 2010;7(10):e1000352. doi:10.1371/journal.pmed.1000352
EFPIA. Code on disclosure of transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations. 6 June 2014.
Mental Health Europe. Shedding light on the relationship between Pharma and the healthcare profession: A mapping of Sunshine and transparency laws, regulations and codes in Europe [Internet]. April 2017. Available from: http://www.mhe-sme.org/fileadmin/Position_papers/Mapping_Sunshine_Laws_Final_01.pdf (Accessed October 2017)
Vitry A. Transparency is good, independence from pharmaceutical industry is better! Aust Prescr. 2016;39(4):112-113. doi:10.18773/austprescr.2016.051
Kmietowicz Z. Disclosure UK website gives "illusion of transparency," says Goldacre. Bmj. 2016;354:i3760. doi:10.1136/bmj.i3760
ABPI. News release. Significant increase in healthcare professionals disclosing partnerships with the pharmaceutical industry. June 30, 2017. Available from: http://www.abpi.org.uk/media-centre/newsreleases/2017/Pages/SIGNIFICANT-INCREASE-IN-HEALTHCARE-PROFESSIONALS-DISCLOSING-PARTNERSHIPS-WITH-THE-PHARMACEUTICAL-INDUSTRY.aspx (Accessed September 2017)
AUTH/2883/10/16 - Voluntary admission by Astellas UK [Internet]. Available from: http://www.pmcpa.org.uk/cases/Pages/2883.aspx.(Accessed January 2018)
Sismondo S. Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won't cast light on. J Law Med Ethics. 2013;41(3):635-643. doi:10.1111/jlme.12073
DeJong C, Aguilar T, Tseng CW, Lin GA, Boscardin WJ, Dudley RA. Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries. JAMA Intern Med. 2016;176(8):1114-1122. doi:10.1001/jamainternmed.2016.2765
Yeh JS, Franklin JM, Avorn J, Landon J, Kesselheim AS. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts. JAMA Intern Med. 2016;176(6):763-768. doi:10.1001/jamainternmed.2016.1709
Perlis RH, Perlis CS. Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs. PLoS One. 2016;11(5):e0155474. doi:10.1371/journal.pone.0155474